Delivery Order SPE2DR25D1053-SPE2DR26FX615

The Defense Logistics Agency issued a $9,024.70 delivery order to AmerisourceBergen Drug Corp on March 30, 2026, for Herceptin 150 mg vials, with a ultimate completion date of April 20, 2026. This is a firm fixed-price call under the DLA Troop Support Medical indefinite delivery contract (SPE2DX), valued at up to $999,999,999 through December 2026, which supplies pharmaceutical products and medical commodities globally to support military healthcare programs. Place of performance is...

<p>The Defense Logistics Agency issued a $1,804.94 delivery order to Amerisourcebergen Drug Corp on March 2, 2026, for Herceptin 150 mg vials, with an ultimate completion date of March 23, 2026.</p> <p>The order is placed under Amerisourcebergen Drug Corp's Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. Pricing is firm fixed price. No set-aside was used.</p>

The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 23, 2026, for Herceptin 150 mg vials with a ceiling value of $1,804.94. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract extending through December 2026 that supplies pharmaceutical products and medical supplies to military healthcare programs globally. Place of performance is Conshohocken, PA. Ultimate completion date is April 13, 2026.

<p>The Defense Logistics Agency issued a $4,512.35 delivery order to Amerisourcebergen Drug Corp on March 2, 2026, for Herceptin 150 mg vials, with ultimate completion on March 23, 2026.</p> <p>The order is issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside applied.</p>

The Defense Logistics Agency awarded a delivery order valued at $5,628.42 to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Herceptin 150 mg vials, with an ultimate completion date of December 4, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract carries no set-aside designation and...

This $21,204.72 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) on May 29, 2024. The contract is for the supply of 4,564,741,632 units of HERCEPTIN 150 MG VIALS, a critical pharmaceutical product, with a period of performance through June 20, 2024. This delivery order is placed under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the...

The Defense Logistics Agency awarded a $21,363.36 delivery order to AmerisourceBergen Drug Corp for 150 mg Herceptin vials, with a completion date of September 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. Herceptin (trastuzumab) is a monoclonal antibody used in cancer treatment, particularly for HER2-positive breast cancer cases, making this a critical pharmaceutical supply...

This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $2,650.59 firm fixed-price delivery order is for the supply of 150 mg vials of the drug Herceptin. The contract has an ultimate completion date of November 5, 2024 and was awarded on October 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which...

The Defense Logistics Agency awarded a delivery order valued at $5,340.84 to AmerisourceBergen Drug Corp for the supply of Herceptin 150 mg vials, a brand-name pharmaceutical product used in cancer treatment. This is a firm fixed-price delivery order with no set-aside designation, issued on September 15, 2025, with an ultimate completion date of October 6, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance location and operates as a...

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,560,875,621 units of the biologic drug Herceptin Hylecta (600mg-10,000 5mL). The fixed-price delivery order, valued at $18,700.96, has a completion date of May 31, 2023. It is not associated with a set-aside program. Amerisourcebergen, a for-profit organization, is the prime contractor and holds a larger $999,999,999 Indefinite Delivery...